Published within
| Type |
Product title / description
|
Pub
|
Price |
CommentWire
|
Published By Datamonitor
|
21 Sep 2001 |
|
CommentWire
|
The UK coalition government is facing legal action from public services trade union UNISON over plans to shake up the National Health Service in a bid to find efficiency savings. However, the proposed reforms could benefit pharmaceutical companies, with patients gaining access to drugs previously blocked by the health service's cost watchdog.
Published By Datamonitor
|
25 Aug 2010 |
|
CommentWire
|
The grossly underfunded NHS is finally receiving some help. The additional funds will be used for modernization, financial incentives, paying debts, and increasing staff - all necessary steps to improve patient care. While this budget increase is only the first step in a 20-year program, any rise in NHS funding is good news for staff, patients - and medical device companies.
Published By Datamonitor
|
19 Apr 2002 |
|
CommentWire
|
Published By Datamonitor
|
06 Apr 2001 |
|
CommentWire
|
George Osborne, the UK chancellor of the exchequer, has attempted to appease branded pharmaceutical manufacturers in his 2011 budget announcement by introducing lower corporate tax rates and increasing R&D incentives. However, it is still unclear as to whether he will go even further and reform the Bolar exemption, which could harm generic drug producers, and lead to a rise in NHS drug spending.
Published By Datamonitor
|
25 Mar 2011 |
|
CommentWire
|
UCB's new rheumatoid arthritis drug, Cimzia, has been recommended for use on the NHS but only in conjunction with a company-sponsored patient access scheme. As such, UCB will cover all treatment costs for the first 12 weeks of therapy. This is a shrewd way of ensuring Cimzia's use by the cost-conscious NHS, and could herald change in both prescribing practices and future NICE submissions.
Published By Datamonitor
|
26 Jan 2010 |
|
ResearchWire
|
Published By Datamonitor
|
05 Jul 2006 |
|
ResearchWire
|
Published By Datamonitor
|
26 Jun 2001 |
|
CommentWire
|
The UK government has recently relaunched the NHS website, an information portal designed to help the public find the health information and services they need. Health websites are already popular with UK consumers and the NHS' ongoing improvements should go some way to meeting remaining patient requirements.
Published By Datamonitor
|
12 Nov 2003 |
|
CommentWire
|
A report on the quality of patient care provided by the nurse-led Internet and telephone service says that NHS Direct is reaching capacity. The findings reflect the growing trend among UK consumers to use new channels to search for health information.
Published By Datamonitor
|
19 Nov 2003 |
|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.